Market Place
Sourcing Support
HemoShear to Participate in SVB Leerink Securities Biopharma Company Connect
18 Oct 2022 //
PRNEWSWIRE
HemoShear Develops Rare Liver Disease Under Research Collaboration with Takeda
10 Aug 2022 //
PR NEWSWIRE
HemoShear Identifies Second Novel Target for NASH in collaboration with Takeda
16 Nov 2021 //
PRNEWSWIRE
HemoShear Advancing Several Novel Compounds for Horizon`s Gout Pipeline
21 Sep 2021 //
PRNEWSWIRE
HemoShear Raises $40 Million in Series A Financing to Advance Rare Disease
10 Feb 2021 //
BIOSPACE
HemoShear ` HST5040 Receives U.S. Orphan Drug Designations
16 Dec 2020 //
PRNEWSWIRE
HemoShear Identifies Novel Drug Target to Treat NASH in Drug Discovery
10 Dec 2020 //
PRNEWSWIRE
HemoShear Enters into Rare Liver Disease Research Collaboration with Takeda
21 Oct 2020 //
PRNEWSWIRE
HemoShear Receives FDA Fast Track & Rare Pediatric Disease or HST5040
28 Jul 2020 //
PRNEWSWIRE
HemoShear Receives FDA Fast Track & Rare Pediatric Disease for HST5040
27 Jul 2020 //
PRNEWSWIRE
HemoShear Receives FDA Clearance of IND for Pha2 Study of its invg Drug HST5040
24 Jun 2020 //
PRNEWSWIRE
Top GSK/ViiV scientist who co-invented an HIV blockbuster books to biotech
25 Sep 2019 //
ENDPTS
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.